- AI in PV
- AI Implementation
- AI Training
- AI Compliance
- Regional Coverage
- Expertise
- QPPV Services
- Medical Safety
- Aggregate Reports
- Signal and Risk Management
- Audits and Due Diligence
- Training and Consultancy
- Digital Transformation
- Technology
Find out about the latest developments and changes happening at iVigee here.
Landmark EU Regulation points to implications for AI in Pharmacovigilance!
The European Union reached an important milestone on Saturday with its proposed regulation of Artificial Intelligence. The EU AI Act comes after intense discussions with EU Member States and the European Parliament, with approval scheduled in Spring 2024 and the act coming into force in 2026. The importance of this comes from what is known as the 2018Brussels Effect 2019, where European changes may inspire global shifts in AI governance.
Complexity and Priorities - Explaining AI in Pharmacovigilance.
Understanding the relevance of AI and Large Language Models (LLMs) like GPT-4 within pharmacovigilance can be difficult, but the key is to demystify their complexity and prioritize explanation.
Whatever your pharmacovigilance requirements, our world-leading technology platforms and globally experienced operational teams can provide the solution.